title: Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination.
abstract: The great potential of mucosal vaccination is widely accepted but progress in the clinical development of subunit mucosal vaccines has been disappointing. Of the available approaches, the use of polymer-based microparticles is attractive because these delivery vehicles can be specifically tailored for vaccines and they offer the potential for integration of adjuvant. Here we address recent developments in the use of particulates as mucosal vaccines and the potential of novel targeting strategies, formulation approaches and adjuvant combinations to enhance the efficacy of particle-based mucosal vaccines. This review discusses the current status of mucosal vaccines based on particles and highlights several of the strategies that are currently under investigation for improving their immunogenicity. These include enhancing the stability of formulations in the luminal environment, increasing uptake by specifically targeting particles to mucosal inductive sites, and augmenting immunogenicity through co-formulation with immunostimulatory agents.
authors: Adjuvant Research Group, School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland. mcneele@tcd.ie
authors: E A
authors: EA
authors: McNeela
authors: E C
authors: EC
authors: Lavelle
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D009092:Mucous Membrane / Q000276:immunology*; D053758:Nanoparticles / Q000737:chemistry*; D014611:Vaccination / Q000295:instrumentation* / Q000379:methods